📖 Complete Guide Updated 2026🔬 Evidence-Based

KPV Guide (2026)

Complete Guide & Evidence (2026)

Alpha-MSH tripeptide fragment with potent anti-inflammatory action. Oral bioavailability for gut inflammation (IBD, IBS).

How KPV Works

🔬

NF-κB Inhibition

Directly blocks the master inflammatory switch. Reduces TNF-α, IL-1β, IL-6 expression. Faster anti-inflammatory onset than full α-MSH

🔬

Oral Bioavailability

Resists gastric acid degradation. Reaches intestinal epithelium intact. Ideal for IBD, IBS, Crohn's protocols

Skin & Wound Action

Reduces cutaneous inflammation via MC1R. Accelerates wound closure in vitro. Topical formulations for eczema, psoriasis

Key Research Snapshots

Reduction in TNF-α in murine colitis models vs. vehicle control.

Typical daily oral dose studied in gut-inflammation research protocols.

Estimated plasma half-life after subcutaneous administration in animal studies.

KPV Protocol Overview

Note: KPV is a research compound. Cycles of 4–8 weeks with a break period are commonly used. Always source from verified peptide suppliers with CoA documentation.

Safety & Side Effects

🔬

Mild / Transient

Injection site redness (subcutaneous). Mild GI upset at high oral doses. Rare: fatigue during initial use

⚠️

Safety Profile

No hepatotoxicity reported in animal studies. No hormonal effects unlike full α-MSH. Well-tolerated at standard research doses

Vital Protocol FAQs

🔬

What is KPV peptide?

KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-MSH (alpha-melanocyte-stimulating hormone) that carries its anti-inflammatory activity. It directly inhibits NF-κB signaling and pro-inflammatory cy

💉

What dose of KPV is typically used?

For gut conditions, oral KPV is typically used at 200–500 mcg per day because it resists digestion and reaches the intestinal epithelium intact. For subcutaneous protocols, 200–300 mcg/day is commonly

🌿

Is KPV safe for the gut?

Preclinical studies show KPV reduced colitis severity in mouse models of IBD by decreasing neutrophil infiltration and pro-inflammatory cytokines. Human data is limited to case reports and small serie

🧬

How does KPV compare to BPC-157 for gut healing?

KPV and BPC-157 address gut inflammation via different pathways. KPV blocks NF-κB and cytokine signaling directly; BPC-157 promotes angiogenesis and growth factor upregulation for mucosal repair. Many

Guide FAQs

Alpha-MSH tripeptide fragment with potent anti-inflammatory action. Oral bioavailability for gut inflammation (IBD, IBS).

Yes. Shotlee supports tracking Kpv doses, side effects, and health metrics. It is free to use.

References

  1. [1]ReviewBrzoska T et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects. Endocr Rev. 2008;29(5):581-602.

Track Your Kpv Protocol in Shotlee

Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.

🚀 Use Shotlee for Free